Positions held by William P. Meyers

This list is to allow users of my reports, analyst conference summaries, and other services to evaluate the independence of my opinions. It is not meant as a set of recommendations. It is a disclosure.

I write on a freelance basis for SeekingAlpha. Like all SeekingAlpha writers, each article discloses whether I own the stock, or other stocks mentioned in the article, at the time the article is written. This site's ads are currently served up by Google.

- William P. Meyers Contact me

Also, while I try to keep this list updated, sometimes there is a lag. Bought dates are of initial purchase; I often accumulate over time and sometimes do partial sales. If there is no link, I am not posting any articles or analyst conference summaries.

 Ticker Symbol  Company
AGEN Agenus [Bought October 2013]
AGIO Agios Pharmaceuticals [Bought December 2015]
AMAT Applied Materials [Bought March, 2008]
AMGN Amgen [bought March 2014]
APRE Aprea [Bought July 2020]
ARWR Arrowhead Pharmaceuticals [bought March 2020]
BIIB Biogen [Bought February 6, 2008]
BMY Bristol Myers-Squib [Bought CELG June 2007]
CDTX Cidera Therapeutics [Bought March 2021]
DRNA Dicerna [Bought September 2020]
EPZM Epizyme [Bought August 2015]
F Ford [Bought March 2020]
GILD Gilead [Bought October 2007]
GLYC Glycomimetics [bought April 2015]
INCY Incyte [bought 11/01/2016]
INO Inovio [bought May 2012]
IONS Ionis Pharmaceuticals [bought August 10, 2017]
MCHP Microchip [bought 2007]
PLX Protalix Biotherapeutics [bought November, 2013]
RNA Avidity Biosceinces [bought March, 2021]
SBLK Star Bulk Carriers [bought July 2015]
SYRS Syros Pharmaceuticals [bought January, 2020]
VBLT Vascular Biogenics [bought June 2016]
WBA Walgreens [bought February 2021]